| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e671f6b1927f8d6c4c42f5a90410d930 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-585 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
| filingDate |
2019-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0e5cd50fd686d85262e339bf2bc6bb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95c3a779c82132ecf8e8f99c6256c8ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b042a8be431dea87949f84bb956f78bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be4e18762f8db58cf85bb9043610c5d4 |
| publicationDate |
2022-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MA-52292-B1 |
| titleOfInvention |
Compounds and their uses for alleviating symptoms associated with menopause |
| abstract |
The present invention relates to hormone replacement therapy, related compounds and related packaging units, for alleviating symptoms associated with menopause which is based on the administration to a female mammal of an estetrol component at a specific daily dose , optionally in combination with a progestogenic component. The treatment enjoys statistically significant efficacy combined with a favorable side effect profile compared to currently available methods for alleviating symptoms associated with menopause. |
| priorityDate |
2018-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |